Deep learning characterization of brain tumours with diffusion weighted imaging.

Applied mathematics Cancer Deep learning Machine learning Mathematical medicine Mathematical oncology Medical imaging Neural networks PDEs

Journal

Journal of theoretical biology
ISSN: 1095-8541
Titre abrégé: J Theor Biol
Pays: England
ID NLM: 0376342

Informations de publication

Date de publication:
21 01 2023
Historique:
received: 28 04 2022
revised: 19 10 2022
accepted: 30 10 2022
pubmed: 12 11 2022
medline: 23 11 2022
entrez: 11 11 2022
Statut: ppublish

Résumé

Glioblastoma multiforme (GBM) is one of the most deadly forms of cancer. Methods of characterizing these tumours are valuable for improving predictions of their progression and response to treatment. A mathematical model called the proliferation-invasion (PI) model has been used extensively in the literature to model the growth of these tumours, though it relies on known values of two key parameters: the tumour cell diffusivity and proliferation rate. Unfortunately, these parameters are difficult to estimate in a patient-specific manner, making personalized tumour forecasting challenging. In this paper, we develop and apply a deep learning model capable of making accurate estimates of these key GBM-characterizing parameters while simultaneously producing a full prediction of the tumour progression curve. Our method uses two sets of multi sequence MRI in order to produce estimations and relies on a preprocessing pipeline which includes brain tumour segmentation and conversion to tumour cellularity. We first apply our deep learning model to synthetic tumours to showcase the model's capabilities and identify situations where prediction errors are likely to occur. We then apply our model to a clinical dataset consisting of five patients diagnosed with GBM. For all patients, we derive evidence-based estimates for each of the PI model parameters and predictions for the future progression of the tumour, along with estimates of the parameter uncertainties. Our work provides a new, easily generalizable method for the estimation of patient-specific tumour parameters, which can be built upon to aid physicians in designing personalized treatments.

Identifiants

pubmed: 36368560
pii: S0022-5193(22)00333-2
doi: 10.1016/j.jtbi.2022.111342
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111342

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Cameron Meaney (C)

Department of Applied Mathematics, University of Waterloo, Waterloo, Canada. Electronic address: cfmeaney@uwaterloo.ca.

Sunit Das (S)

Division of Neurosurgery, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada; Faculty of Medicine, University of Toronto, Toronto, Canada.

Errol Colak (E)

Faculty of Medicine, University of Toronto, Toronto, Canada; Department of Medical Imaging and Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada; Odette Professorship in Artificial Intelligence for Medical Imaging, St. Michael's Hospital, Toronto, Canada.

Mohammad Kohandel (M)

Department of Applied Mathematics, University of Waterloo, Waterloo, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH